论文信息 - Management Principles Associated With Cytokine Release Syndrome. - 字舞流文

Management Principles Associated With Cytokine Release Syndrome.

Channing Vail Dudley | Brittney Baer | R. Simons | Rhea M Simons | Channing V Dudley

[1] K. Anderson,et al. Associated Toxicities: Assessment and management related to CAR T‐cell therapy , 2019, Clinical journal of oncology nursing.

[2] Daniel W. Lee,et al. Current approaches in the grading and management of cytokine release syndrome after chimeric antigen receptor T-cell therapy , 2019, Therapeutics and clinical risk management.

[3] Juliet Investigators. Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma , 2019 .

[4] S. Grupp,et al. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5] P. Hwu,et al. Chimeric antigen receptor T-cell therapy — assessment and management of toxicities , 2018, Nature Reviews Clinical Oncology.

[6] R. Levy,et al. Axicabtagene Ciloleucel CAR T‐Cell Therapy in Refractory Large B‐Cell Lymphoma , 2017, The New England journal of medicine.

[7] N. Bartlett,et al. Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[8] S. Grupp,et al. Current concepts in the diagnosis and management of cytokine release syndrome. , 2014, Blood.